Targeting enhanced neutralizing antibody responses via increased germinal center activity: early-phase vaccine trials with novel clinical designs

WO Hahn, JA Hill, JG Kublin - Current Opinion in HIV and AIDS, 2023 - journals.lww.com
Current Opinion in HIV and AIDS Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

Sustained exposure to multivalent antigen-decorated nanoparticles generates broad anti-coronavirus responses

J Baillet, JH Klich, BS Ou, EL Meany, J Yan, TUJ Bruun… - bioRxiv, 2024 - biorxiv.org
The threat of future coronavirus pandemics requires develo** cost-effective vaccine
technologies that provide broad and long-lasting protection against diverse circulating and …

Generation of an inflammatory niche in an injectable hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccines

EL Meany, JH Klich, CK Jons, T Mao, N Chaudhary… - bioRxiv, 2024 - biorxiv.org
Messenger RNA (mRNA) delivered in lipid nanoparticles (LNPs) rose to the forefront of
vaccine candidates during the COVID-19 pandemic due in part to scalability, adaptability …